Fig. 4

Overall survival (a) and lung cancer-specific survival (b) for patients with T1N0 SCLC who underwent surgery or surgery + postoperative radiotherapy (PORT) and overall survival (c) and lung cancer-specific survival (d) for patients with T2N0 SCLC who underwent surgery or surgery + PORT